Advertisement

Magnetic resonance enterography in Crohn’s disease: new simple proposal to assess disease activity

Published:November 23, 2015DOI:https://doi.org/10.1016/j.clinimag.2015.11.009

      Abstract

      Purpose

      The aim is to determine the accuracy of magnetic resonance enterography (MRE) in evaluating Crohn’s disease (CD) activity.

      Materials and methods

      Seventy-seven patients with CD underwent MRE. The primary analysis was to determine associations between MRE findings, Harvey–Bradshaw Index, and C-reactive protein (CRP), then we have created a new MRE score that it was also correlated with clinical and laboratory data.

      Results

      MRE score for CD significantly correlates with CRP (P=.003). Significant associations were found between degree of contrast enhancement and CRP (P=.002) and between comb sign and CRP (P=.001).

      Conclusions

      These results make MRE an important instrument for evaluation of CD activity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Martin DR
        • Lauenstein T
        • Sitaraman SV
        Utility of magnetic resonance imaging in small bowel Crohn’s disease.
        Gastroenterology. 2007; 133: 385-390
        • Van Assche G
        • Dignass A
        • Panes J
        • Beaugerie L
        • Karagiannis J
        • Allez M
        • et al.
        The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis.
        J Crohns Colitis. 2010; 4: 7-27
        • Singleton JW
        Clinical activity assessment in inflammatory bowel disease.
        Dig Dis Sci. 1987; 32: 42S-45S
        • Pariente B
        • Cosnes J
        • Danese S
        • Sandborn WJ
        • Lewin M
        • Fletcher JG
        • et al.
        Development of the Crohn’s disease digestive damage score, the Lemann score.
        Inflamm Bowel Dis. 2011; 17: 1415-1422
        • Carter MJ
        • Lobo AJ
        • Travis SP
        • Singleton JW
        Guidelines for the management of inflammatory bowel disease in adults.
        Gut. 2004; 53: V1-V16
        • Best WR
        Predicting the Crohn’s disease activity index from the Harvey–Bradshaw Index.
        Inflamm Bowel Dis. 2006; 12: 304-310
        • Harvey RF
        • Bradshaw JM
        A simple index of Crohn’s-disease activity.
        Lancet. 1980; 1: 514
        • Vermeire S
        • Van Assche G
        • Rutgeerts P
        C-reactive protein as a marker for inflammatory bowel disease.
        Inflamm Bowel Dis. 2004; 10: 661-665
        • Daperno M
        • D’Haens G
        • Van Assche G
        • Baert F
        • Bulois P
        • Maunoury V
        • et al.
        Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD.
        Gastrointest Endosc. 2004; 60: 505-512
        • Tolan DJ
        • Greenhalgh R
        • Zealley IA
        • Halligan S
        • Taylor SA
        MR enterographic manifestations of small bowel Crohn disease.
        Radiographics. 2010; 30: 367-384
        • Amitai MM
        • Ben-Horin S
        • Eliakim R
        • Kopylov U
        Magnetic resonance enterography in Crohn’s disease: a guide to common imaging manifestations for the IBD physician.
        J Crohns Colitis. 2013; 7: 603-615
        • Sinha R
        • Rajiah P
        • Murphy P
        • Hawker P
        • Sanders S
        Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in Crohn disease.
        Radiographics. 2009; 29: 1847-1867
        • Pariente B
        • Peyrin-Biroulet L
        • Cohen L
        • Zagdanski AM
        • Colombel JF
        Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease.
        AJR Am J Roentgenol. 2011; 197: 42-49
        • Maccioni F
        • Viscido A
        • Broglia L
        • Marrollo M
        • Masciangelo R
        • Caprilli R
        • et al.
        Evaluation of Crohn disease activity with magnetic resonance imaging.
        Abdom Imaging. 2000; 25: 219-228
        • Steward MJ
        • Punwani S
        • Proctor I
        • Adjei-Gyamfi Y
        • Chatterjee F
        • Bloom S
        • et al.
        Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.
        Eur J Radiol. 2012; 81: 2080-2088
        • Horsthuis K
        • Bipat S
        • Stokkers PC
        • Stoker J
        Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review.
        Eur Radiol. 2009; 19: 1450-1460
        • Del Vescovo R
        • Sansoni I
        • Caviglia R
        • Ribolsi M
        • Perrone G
        • Leoncini E
        • et al.
        Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease.
        Abdom Imaging. 2008; 33: 417-424
        • Rimola J
        • Rodriguez S
        • Garcia-Bosch O
        • Ordás I
        • Ayala E
        • Aceituno M
        • et al.
        Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease.
        Gut. 2009; 58: 1113-1120
        • Macarini L
        • Stoppino LP
        • Centola A
        • Muscarella S
        • Fortunato F
        • Coppolino F
        • et al.
        Assessment of activity of Crohn’s disease of the ileum and large bowel: proposal for a new multiparameter MR enterography score.
        Radiol Med. 2013; 118: 181-195
        • Best WR
        • Becktel JM
        • Singleton JW
        • Kern Jr, F
        • et al.
        Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study.
        Gastroenterology. 1976; 70: 439-444
        • Jaffe TA
        • Gaca AM
        • Delaney S
        • Yoshizumi TT
        • Toncheva G
        • Nguyen G
        • et al.
        Radiation doses from small-bowel follow-through and abdominopelvic MDCT in Crohn’s disease.
        AJR Am J Roentgenol. 2007; 189: 1015-1022
        • Peloquin JM
        • Pardi DS
        • Sandborn WJ
        • Fletcher JG
        • McCollough CH
        • Schueler BA
        • et al.
        Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease.
        Am J Gastroenterol. 2008; 103: 2015-2022
        • Ziech ML
        • Bossuyt PM
        • Laghi A
        • Lauenstein TC
        • Taylor SA
        • Stoker J
        Grading luminal Crohn’s disease: which MRI features are considered as important?.
        Eur J Radiol. 2012; 81: e467-e472
        • Makanyanga JC
        • Pendse D
        • Dikaios N
        • Bloom S
        • McCartney S
        • Helbren E
        • et al.
        Evaluation of Crohn’s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.
        Eur Radiol. 2014; 24: 277-287
        • Punwani S
        • Rodriguez-Justo M
        • Bainbridge A
        • Greenhalgh R
        • De Vita E
        • Bloom S
        • et al.
        Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.
        Radiology. 2009; 252: 712-720